Agency Information Collection Activities: Proposed Collection; Comment Request, 24211 [2012-9662]
Download as PDF
<![CDATA[
24211
Federal Register / Vol. 77, No. 78 / Monday, April 23, 2012 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
(2009, incl.
H1N1)
Form
Airline Travel Illness or Death Investigation Form ..........................................
Maritime Conveyance Illness or Death Investigation Form .............................
Land Travel Illness or Death Investigation Form ............................................
Total ..........................................................................................................
Dated: April 17, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science (OADS),
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–9717 Filed 4–20–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
1626
1873
259
3,758
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Enhancing Substance
Abuse Treatment Services To Address
Hepatitis Infection Among Intravenous
Drug Users Hepatitis Testing and
Vaccine Tracking Form (OMB No.
0930–0300)—Extension
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center Substance Abuse
Treatment (CSAT), is responsible for the
Hepatitis Testing and Vaccine Tracking
Form for the prevention of Viral
Hepatitis in patients in designated
Opioid Treatment Programs (OTPs).
There are no changes to the form or
added burden.
This form allows SAMHSA/CSAT to
collect essential Clinical information
that will be used for quality assurance,
quality performance and product
monitoring on approximately 264 Rapid
Hepatitis C Test kits and 10,628 doses
of hepatitis vaccine (Twinrix, HAV, or
HBV). The above kits and vaccines will
be provided to designated OTPs serving
the minority population in their
communities. The information collected
on the Form solicits and reflect the
following information:
Number of
responses per
respondent
Average
burden
per response
(in minutes)
1
1
1
........................
5/60
7/60
5/60
........................
Total burden
hours
136
219
22
377
• Demographics (age, gender, ethnicity)
of designated OTP site
• History (Screening) of Hepatitis C
exposure
• Results of Rapid Hepatitis C Testing
(Kit) and Follow-up information
• Service Provided (type of vaccine
given) Divalent vaccine (Twinrixcombination HAV and HBV) or
Monovalent vaccine (HAV and/or
HBV)
• Substance Abuse Treatment
Outcomes (Information regarding the
beginning, continuing or completion
of vaccination series)
• Type of Referral Services Indicated
(i.e., Gastroenterology, TB; Mental
Health, Counseling, Reproductive/
Prenatal, etc.)
This program is authorized under
Section 509 of the Public Health Service
(PHS) Act [42 U.S.C. 290bb–2].
The form increases the screening and
reporting of viral hepatitis in high risk
minorities in OTPs. The information
collected allows SAMHSA to address
the increased morbidity and mortality of
hepatitis in minorities being treated for
drug addiction.
The SAMHSA/CSAT Hepatitis
Testing and Vaccine Tracking Form
supports quality of care, provide
minimum but adequate clinical and
product monitoring, and provide
appropriate safeguards against fraud,
waste and abuse of Federal funds.
The table below reflects the
annualized hourly burden.
Responses/
respondent
Burden hours
Total burden
hours
50,000 ..........................................................................................................................................
rmajette on DSK2TPTVN1PROD with NOTICES
Number of respondents screened
1
0.05
2,500
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 8–1099, One Choke Cherry Road,
Rockville, MD 20857 or email her a
copy at summer.king@samhsa.hhs.gov.
Written comments must be received
before 60 days after the publication in
the Federal Register.
DEPARTMENT OF HOMELAND
SECURITY
Summer King,
Statistician.
Coast Guard
[FR Doc. 2012–9662 Filed 4–20–12; 8:45 am]
BILLING CODE 4162–20–P
[USCG–2012–0274]
Information Collection Requests to
Office of Management and Budget
AGENCY:
VerDate Mar<15>2010
15:11 Apr 20, 2012
Jkt 226001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
E:\FR\FM\23APN1.SGM
Coast Guard, DHS.
23APN1
]]>Agencies
[Federal Register Volume 77, Number 78 (Monday, April 23, 2012)]
[Notices]
[Page 24211]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-9662]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Enhancing Substance Abuse Treatment Services To
Address Hepatitis Infection Among Intravenous Drug Users Hepatitis
Testing and Vaccine Tracking Form (OMB No. 0930-0300)--Extension
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) Center Substance Abuse Treatment (CSAT), is responsible for
the Hepatitis Testing and Vaccine Tracking Form for the prevention of
Viral Hepatitis in patients in designated Opioid Treatment Programs
(OTPs). There are no changes to the form or added burden.
This form allows SAMHSA/CSAT to collect essential Clinical
information that will be used for quality assurance, quality
performance and product monitoring on approximately 264 Rapid Hepatitis
C Test kits and 10,628 doses of hepatitis vaccine (Twinrix, HAV, or
HBV). The above kits and vaccines will be provided to designated OTPs
serving the minority population in their communities. The information
collected on the Form solicits and reflect the following information:
Demographics (age, gender, ethnicity) of designated OTP site
History (Screening) of Hepatitis C exposure
Results of Rapid Hepatitis C Testing (Kit) and Follow-up
information
Service Provided (type of vaccine given) Divalent vaccine
(Twinrix-combination HAV and HBV) or Monovalent vaccine (HAV and/or
HBV)
Substance Abuse Treatment Outcomes (Information regarding the
beginning, continuing or completion of vaccination series)
Type of Referral Services Indicated (i.e., Gastroenterology,
TB; Mental Health, Counseling, Reproductive/Prenatal, etc.)
This program is authorized under Section 509 of the Public Health
Service (PHS) Act [42 U.S.C. 290bb-2].
The form increases the screening and reporting of viral hepatitis
in high risk minorities in OTPs. The information collected allows
SAMHSA to address the increased morbidity and mortality of hepatitis in
minorities being treated for drug addiction.
The SAMHSA/CSAT Hepatitis Testing and Vaccine Tracking Form
supports quality of care, provide minimum but adequate clinical and
product monitoring, and provide appropriate safeguards against fraud,
waste and abuse of Federal funds.
The table below reflects the annualized hourly burden.
----------------------------------------------------------------------------------------------------------------
Responses/ Total burden
Number of respondents screened respondent Burden hours hours
----------------------------------------------------------------------------------------------------------------
50,000....................................................... 1 0.05 2,500
----------------------------------------------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
Room 8-1099, One Choke Cherry Road, Rockville, MD 20857 or email her a
copy at summer.king@samhsa.hhs.gov. Written comments must be received
before 60 days after the publication in the Federal Register.
Summer King,
Statistician.
[FR Doc. 2012-9662 Filed 4-20-12; 8:45 am]
BILLING CODE 4162-20-P
